Use of Anthracyclines Should Be Re-Evaluated for Treatment of Breast Cancer
According to Sara Hurvitz, medical oncologist, and professor of medicine at the University of Washington, Fred Hutchinson Cancer Center the severe side effects of anthracyclines
are underestimated in the treatment of breast cancer. In this MEDtalk, Sarah Hurvitz argues why the use of anthracyclines should be re-evaluated.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
